Joseph A. Walder
Integrated DNA Technologies
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Joseph A. Walder.
Molecular therapy. Nucleic acids | 2013
Kim A. Lennox; Richard Owczarzy; Derek M. Thomas; Joseph A. Walder; Mark A. Behlke
Anti-microRNA oligonucleotides (AMOs) are steric blocking antisense reagents that inhibit microRNA (miRNA) function by hybridizing and repressing the activity of a mature miRNA. First generation AMOs employed 2′-O-Methyl RNA nucleotides (2′OMe) with phosphorothioate (PS) internucleotide linkages positioned at both ends to block exonuclease attack. Second generation AMOs improved potency through the use of chemical modifications that increase binding affinity to the target, such as locked nucleic acid (LNA) residues. However, this strategy can reduce specificity as high binding affinity compounds can bind to and suppress function of related sequences even if one or more mismatches are present. Further, unnatural modified nucleic acid residues can have toxic side effects. In the present study, a variety of non-nucleotide modifiers were screened for utility in steric blocking antisense applications. A novel compound, N,N-diethyl-4-(4-nitronaphthalen-1-ylazo)-phenylamine (“ZEN”), was discovered that increased binding affinity and blocked exonuclease degradation when placed at or near each end of a single-stranded oligonucleotide. This new modification was combined with the 2′OMe RNA backbone to make ZEN-AMOs. The new ZEN-AMOs have high potency and can effectively inhibit miRNA function in vitro at low nanomolar concentrations, show high specificity, and have low toxicity in cell culture.
BMC Biotechnology | 2011
Joseph Dobosy; Scott Rose; Kristin Beltz; Susan Rupp; Kristy M Powers; Mark A. Behlke; Joseph A. Walder
BackgroundThe polymerase chain reaction (PCR) is commonly used to detect the presence of nucleic acid sequences both in research and diagnostic settings. While high specificity is often achieved, biological requirements sometimes necessitate that primers are placed in suboptimal locations which lead to problems with the formation of primer dimers and/or misamplification of homologous sequences.ResultsPyrococcus abyssi (P.a.) RNase H2 was used to enable PCR to be performed using blocked primers containing a single ribonucleotide residue which are activated via cleavage by the enzyme (rhPCR). Cleavage occurs 5-to the RNA base following primer hybridization to the target DNA. The requirement of the primer to first hybridize with the target sequence to gain activity eliminates the formation of primer-dimers and greatly reduces misamplification of closely related sequences. Mismatches near the scissile linkage decrease the efficiency of cleavage by RNase H2, further increasing the specificity of the assay. When applied to the detection of single nucleotide polymorphisms (SNPs), rhPCR was found to be far more sensitive than standard allele-specific PCR. In general, the best discrimination occurs when the mismatch is placed at the RNA:DNA base pair.ConclusionrhPCR eliminates the formation of primer dimers and markedly improves the specificity of PCR with respect to off-target amplification. These advantages of the assay should find utility in challenging qPCR applications such as genotyping, high level multiplex assays and rare allele detection.
Nucleic Acids Research | 1990
John M. Dagle; Joseph A. Walder; Daniel L. Weeks
Antisense research and development | 1991
John M. Dagle; Daniel L. Weeks; Joseph A. Walder
Nucleic Acids Research | 1991
John M. Dagle; Mark E. Andracki; Rene J. DeVine; Joseph A. Walder
Archive | 2009
Joseph A. Walder; Mark A. Behlke; Scott Rose; Josesph Dobosy
Nucleic Acids Research | 1993
Roxanne Y. Walder; Janel R. Hayes; Joseph A. Walder
Archive | 2008
Andrei Laikhter; Mark A. Behlke; Joseph A. Walder; Kevin William Roberts; Yawfui Yong
Archive | 2009
Andrei Laikhter; Joseph A. Walder; Mark A. Behlke; Mikhail Podyminogin; Yawfui Yong
Archive | 1994
Joseph A. Walder; Roxanne Y. Walder; Paul S. Eder; John M. Dagle